Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;199(6):607-610.
doi: 10.1007/s00066-023-02087-5. Epub 2023 May 8.

Präoperative Therapie beim Pankreaskarzinom: Daten der A021501-Studie

[Article in German]
Katarzyna Paal  1 , Thomas Brunner  2
Affiliations

Präoperative Therapie beim Pankreaskarzinom: Daten der A021501-Studie

[Article in German]
Katarzyna Paal et al. Strahlenther Onkol. 2023 Jun.
No abstract available

PubMed Disclaimer

References

Literatur

    1. Brunner TB, Haustermans K, Huguet F et al (2021) ESTRO ACROP guidelines for target volume definition in pancreatic cancer. Radiother Oncol 154:60–69 - DOI - PubMed
    1. Hermann RM, Christiansen H (2021) Preoperative radiochemotherapy improves oncological results in borderline resectable pancreatic cancer, but not overall survival in resectable cancers : results from the Dutch PREOPANC study. Strahlenther Onkol 197:85–88 - DOI - PubMed
    1. Holyoake DLP, Robinson M, Silva M et al (2021) SPARC, a phase‑I trial of pre-operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer. Radiother Oncol 155:278–284 - DOI - PubMed
    1. Katz MHG, Shi Q, Meyers J, Herman JM et al (2022) Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: the A021501 phase 2 randomized clinical trial. JAMA Oncol 8:1263–1270 - DOI - PubMed
    1. Oar A, Lee M, Le H et al (2021) AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer. BMC Cancer 21:936 - DOI - PubMed - PMC